エピソード

  • How Digital Health Platforms Are Integrating with Primary Care EHRs

    How Digital Health Platforms Are Integrating with Primary Care EHRs
    2026/06/08
    Lucas and Luna explore the messy, high-stakes world of EHR integration for digital health platforms. They focus on a specific case: how a chronic care management startup called Rimidi built a direct bridge into Epic Systems, the dominant EHR used by over 250 million patients in the US. The hosts walk through the technical hurdles, the data-privacy landmines, and the business incentives that make or break these integrations. They discuss Rimidi's decision to embed its hypertension and diabetes workflows directly into the clinician's existing screen rather than creating a separate app — and why that choice matters for adoption. The episode also touches on the broader trend of EHRs becoming platforms, with reference to Apple Health Records and the HL7 FHIR standard. No hype, just the reality of getting software to talk to hospital systems. #EHRIntegration #DigitalHealth #EpicSystems #Rimidi #HealthTech #PrimaryCare #FHIR #PlatformStrategy #ChronicCare #Interoperability #ClinicalWorkflow #DataPrivacy #AppleHealthRecords #HealthIT #BusinessAndTechnology #FexingoBusiness #BusinessPodcast #PodcastEpisode Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    11 分
  • How Smart Rings Are Replacing Fitness Trackers for Sleep and Health

    How Smart Rings Are Replacing Fitness Trackers for Sleep and Health
    2026/06/08
    Episode 38 of The Digital Health Podcast explores the quiet rise of smart rings—wearables that pack sensors into a jewelry form factor. Lucas and Luna examine how Oura, Samsung, and startups like Circular are competing to track sleep, heart rate, and temperature without a wristband. They dig into the clinical research backing ring-based sleep staging, why insurers are starting to subsidize them for employee wellness programs, and the privacy trade-offs of always-on biometric data stored in the cloud. The hosts also touch on the latest FDA clearance for an atrial fibrillation detection algorithm in a smart ring, and ask whether rings will eventually make smartwatches redundant for health monitoring. Tune in for a focused look at the smallest device in digital health—and why it might have the biggest impact on preventive care. #SmartRings #Oura #SamsungGalaxyRing #CircularRing #WearableTech #SleepTracking #HeartRateMonitoring #DigitalHealth #FDA #AtrialFibrillation #EmployeeWellness #HealthTech #Biometrics #Privacy #PreventiveCare #Business #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    10 分
  • How Wearable Skin Patches Are Replacing Needles for Drug Delivery

    How Wearable Skin Patches Are Replacing Needles for Drug Delivery
    2026/06/07
    In this episode of The Digital Health Podcast, Lucas and Luna explore the emerging world of wearable microneedle patches that deliver drugs through the skin without pain. They focus on the specific case of Zosano Pharma's transdermal patch for migraine, which failed in clinical trials in 2021, and contrast it with newer players like Vaxxas and LTS Lohmann that are targeting vaccines and insulin. Lucas breaks down the key engineering challenge: how to make microneedles long enough to penetrate the stratum corneum but short enough to avoid pain receptors. Luna asks whether the FDA's regulatory pathway for combination products is slowing adoption. The hosts also discuss the potential market size: Grand View Research estimates the transdermal drug delivery market could reach $12.3 billion by 2027. They debate whether the biggest win will be in chronic disease management (insulin, GLP-1 agonists) or mass vaccination campaigns. The episode ties the conversation to listener support, noting that independent digital health journalism helps separate real innovation from hype. A focused, technical conversation for anyone interested in how wearables are moving beyond sensors into therapeutics. #DigitalHealth #WearableTech #MicroneedlePatches #DrugDelivery #Transdermal #ZosanoPharma #Vaxxas #LTSLohmann #Migraine #Insulin #GLP1 #FDA #CombinationProducts #Business #Technology #FexingoBusiness #BusinessPodcast #HealthTech Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    11 分
  • How Digital Health Startups Are Redesigning the Doctor Visit

    How Digital Health Startups Are Redesigning the Doctor Visit
    2026/06/07
    Lucas and Luna explore how a handful of digital health startups are rethinking the primary care visit from the ground up. The episode focuses on 'ambient listening' AI — software that listens to the patient-clinician conversation and automatically generates clinical notes, diagnoses, and billing codes in real time. They examine the specific case of Abridge, which recently partnered with several major health systems, and discuss the numbers: how much time physicians actually spend on documentation (around 15 minutes per appointment after hours), and how ambient listening aims to cut that to zero. They also touch on the tricky regulatory question — when an AI listens in, who owns the transcript? And what happens when the model makes a clinical error in its note? The hosts treat the topic with a sharp business lens, comparing the unit economics of ambient listening to traditional medical scribes (human scribes cost roughly $15 to $20 per hour; AI scribes are targeting $1 to $2 per visit). The episode closes with a forward-looking question: if the listening is automated, and the note-taking is automated, what part of the doctor-patient relationship becomes the truly human middle? #AmbientListening #AIinHealthcare #PrimaryCare #DigitalHealth #Abridge #MedicalScribes #ClinicianBurnout #HealthTech #Business #FexingoBusiness #BusinessPodcast #DoctorPatient #EHR #Documentation #HealthAI #Startup #Podcast #Technology Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    10 分
  • How MedTech Startups Are Navigating the FDA's Software Pathway

    How MedTech Startups Are Navigating the FDA's Software Pathway
    2026/06/06
    In episode 35 of The Digital Health Podcast, Lucas and Luna unpack the FDA's evolving framework for regulating software-as-a-medical-device (SaMD). They focus on the agency's 2025 guidance on AI/ML-enabled devices and how it affects startups like IDx and Caption Health. Lucas explains the 'predetermined change control plan'—a mechanism that lets algorithms update without full re-clearance. Luna questions whether this really accelerates innovation or just shifts risk. They also discuss the de novo pathway, the 510(k) exemption for low-risk tools, and why some digital health companies are choosing not to pursue FDA clearance at all. A concrete look at regulatory strategy for anyone building or investing in health software. #DigitalHealth #SaMD #FDA #SoftwareAsAMedicalDevice #AIinHealthcare #MedTech #RegulatoryStrategy #IDx #CaptionHealth #PredeterminedChangeControlPlan #510kClearance #DeNovoPathway #Business #Technology #HealthTech #FexingoBusiness #BusinessPodcast #DigitalTherapeutics Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    9 分
  • How Remote Patient Monitoring Is Reshaping Primary Care

    How Remote Patient Monitoring Is Reshaping Primary Care
    2026/06/06
    Remote patient monitoring has moved beyond chronic disease management into mainstream primary care. Lucas and Luna examine a specific case: a midsize clinic network in Ohio that deployed cellular-connected blood pressure cuffs and pulse oximeters for 2,000 patients with hypertension. They discuss the early results — a 14 percent reduction in systolic blood pressure over six months — and the operational challenges of integrating device data into electronic health records. The conversation also covers the financial incentives: Medicare's RPM billing codes now reimburse roughly $110 per patient per month, making the model viable for independent practices. But questions remain about equity, data burden, and whether RPM widens or closes the care gap. A grounded look at what's actually working in remote monitoring today, with real numbers and real trade-offs. #RemotePatientMonitoring #PrimaryCare #Hypertension #RPM #Medicare #DigitalHealth #HealthTech #Wearables #BloodPressure #PulseOximetry #EHR #ClinicalOutcomes #HealthcareCosts #HealthEquity #Business #Technology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    11 分
  • How AI Is Reading Retinal Images for Disease Screening

    How AI Is Reading Retinal Images for Disease Screening
    2026/06/05
    Episode 33 of The Digital Health Podcast with Fexingo explores how artificial intelligence is analyzing retinal scans to detect signs of diabetic retinopathy, cardiovascular disease, and even Alzheimer's risk years before symptoms appear. Lucas and Luna zero in on the FDA-cleared system from IDx-DR (now LumineticsCore) and the new wave of deep learning models trained on millions of fundus photographs. They discuss the clinical validation data from a 2024 JAMA study, the workflow integration challenges in primary care offices, and why reimbursement codes are the bottleneck for scaling. No hype, just the real metrics: sensitivity above 87% in real-world deployment and the false-positive tradeoffs that keep regulators cautious. If you're following where computer vision meets clinical workflow, this is the episode that cuts through the noise. #AI #RetinalImaging #DiabeticRetinopathy #IDxDR #LumineticsCore #ComputerVision #DeepLearning #FDACleared #JAMA #Screening #PrimaryCare #Ophthalmology #DigitalHealth #HealthTech #Diagnostics #BusinessAndTechnology #FexingoBusiness #BusinessPodcast Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    9 分
  • How Wearable Sensors Are Detecting Early Infections

    How Wearable Sensors Are Detecting Early Infections
    2026/06/05
    Lucas and Luna explore how wearables like the Oura Ring and Apple Watch can detect early signs of viral infections before symptoms appear. They discuss the 2020 study from Stanford that showed temperature changes and heart rate variability shifts preceding COVID-19 symptoms by 2-3 days, and how companies like Fitbit are now building disease-detection algorithms. The hosts drill into the specific physiological signals — resting heart rate, skin temperature, respiratory rate — and why the FDA is treating these as a new class of pre-symptomatic screening tools. They also examine the privacy trade-offs: who owns the infection data? Do employers get access? And what happens when a wearable flags an infection that doesn't exist? The episode unpacks the technology, the regulatory landscape, and the ethical questions that come with turning a consumer gadget into a public health sensor. #Wearables #EarlyInfectionDetection #OuraRing #AppleWatch #Fitbit #FDA #HealthTech #DigitalHealth #Biometrics #HeartRateVariability #SkinTemperature #MachineLearning #Privacy #StanfordStudy #COVID19 #Business #Technology #FexingoBusiness Keep every episode free: buymeacoffee.com/fexingo
    続きを読む 一部表示
    15 分